Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gal Dinstag

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Bioinformatics (Oxford, England)|November 5, 2019
PRODIGY: personalized prioritization of driver genesGal Dinstag, Ron Shamir
Plos One|August 9, 2019
Personalized prediction of adverse heart and kidney events using baseline and longitudinal data from SPRINT and ACCORDGal Dinstag, David Amar, Erik Ingelsson, et al.
Journal for Immunotherapy of Cancer|January 5, 2023
Fibrolamellar carcinoma transcriptomic-based treatment prediction: complete response after nivolumab and ipilimumabRaanan Berger, Gal Dinstag, Omer Tirosh, et al.
Oral Oncology|July 31, 2025
Prediction of clinical outcomes of immune checkpoint inhibitors in advanced head and neck cancer directly from histopathology slides using inferred transcriptomicsAnna Elia, Omer Tirosh, Gal Dinstag, et al.
Frontiers in Immunology|May 29, 2026
Prediction of clinical outcomes of advanced cutaneous squamous cell carcinoma to PD-1 inhibition directly from histopathology slides using inferred transcriptomicsBohdana Chayen, Gal Dinstag, Omer Tirosh, et al.
Journal for Immunotherapy of Cancer|January 12, 2025
Predictive value of ENLIGHT-DP in patients with metastatic lung adenocarcinoma treated with immune checkpoint inhibitors and platinum chemotherapy directly from histopathology slides using inferred transcriptomicsJohnathan Arnon, Gal Dinstag, Omer Tirosh, et al.
NPJ Precision Oncology|June 15, 2026
Longitudinal validation of ENLIGHT, an AI predictor of immunotherapy response and resistance, in pan-cancer cohortsChangsu L Park, Gal Dinstag, Carlos D Holanda Lopes, et al.
Cell|April 15, 2021
Synthetic lethality-mediated precision oncology via the tumor transcriptomeJoo Sang Lee, Nishanth Ulhas Nair, Gal Dinstag, et al.
Research Square|June 5, 2026
SYNTHESIS-Breast: A prospective early-phase trial of a genetic-interaction- focused computational algorithm in advanced metastatic breast cancerAanika B Warner, Britanny B Solarz, Miroslava Belyov, et al.
Research Square|October 4, 2023
Prediction of cancer treatment response from histopathology images through imputed transcriptomicsDanh-Tai Hoang, Gal Dinstag, Leandro C Hermida, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Bioinformatics (Oxford, England)|November 5, 2019
PRODIGY: personalized prioritization of driver genesGal Dinstag, Ron Shamir
Plos One|August 9, 2019
Personalized prediction of adverse heart and kidney events using baseline and longitudinal data from SPRINT and ACCORDGal Dinstag, David Amar, Erik Ingelsson, et al.
Journal for Immunotherapy of Cancer|January 5, 2023
Fibrolamellar carcinoma transcriptomic-based treatment prediction: complete response after nivolumab and ipilimumabRaanan Berger, Gal Dinstag, Omer Tirosh, et al.
Oral Oncology|July 31, 2025
Prediction of clinical outcomes of immune checkpoint inhibitors in advanced head and neck cancer directly from histopathology slides using inferred transcriptomicsAnna Elia, Omer Tirosh, Gal Dinstag, et al.
Frontiers in Immunology|May 29, 2026
Prediction of clinical outcomes of advanced cutaneous squamous cell carcinoma to PD-1 inhibition directly from histopathology slides using inferred transcriptomicsBohdana Chayen, Gal Dinstag, Omer Tirosh, et al.
Journal for Immunotherapy of Cancer|January 12, 2025
Predictive value of ENLIGHT-DP in patients with metastatic lung adenocarcinoma treated with immune checkpoint inhibitors and platinum chemotherapy directly from histopathology slides using inferred transcriptomicsJohnathan Arnon, Gal Dinstag, Omer Tirosh, et al.
NPJ Precision Oncology|June 15, 2026
Longitudinal validation of ENLIGHT, an AI predictor of immunotherapy response and resistance, in pan-cancer cohortsChangsu L Park, Gal Dinstag, Carlos D Holanda Lopes, et al.
Cell|April 15, 2021
Synthetic lethality-mediated precision oncology via the tumor transcriptomeJoo Sang Lee, Nishanth Ulhas Nair, Gal Dinstag, et al.
Research Square|June 5, 2026
SYNTHESIS-Breast: A prospective early-phase trial of a genetic-interaction- focused computational algorithm in advanced metastatic breast cancerAanika B Warner, Britanny B Solarz, Miroslava Belyov, et al.
Research Square|October 4, 2023
Prediction of cancer treatment response from histopathology images through imputed transcriptomicsDanh-Tai Hoang, Gal Dinstag, Leandro C Hermida, et al.
Pageof 2